Physician

Adam Hsu, M.D.

According to 2025 Medicare claims, Adam Hsu, M.D. (NPI: 1699825083) practices ophthalmology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is CALIFORNIA VISION AND VISAGE MEDICAL GROUP INC (NPI: 1609105451; TIN: 27-1434580) and primary practice location at 91748-1384. Hsu is affiliated with the APA ACO Inc. (ACO ID: D0215), participating under the REACH model.

Hsu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 740 traditional Medicare patients, billed 3,607 HCPCS/CPT codes, and received $124,147 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 4,792 prescription claims across 811 beneficiaries totaling $544,422 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 32 records totaling $610. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $77,973 to $124,147. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $171,102 to $544,422. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.